All Stories

  1. Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

    Article • OncoTargets and Therapy, May 2016, Dove Medical Press

    Dr Tom P Shakespeare, Dr Noel John Aherne

  2. Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?

    Article • OncoTargets and Therapy, March 2016, Dove Medical Press

    Dr Noel John Aherne, Dr Tom P Shakespeare

  3. Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration

    Article • Asia-Pacific Journal of Clinical Oncology, September 2014, Wiley

    Dr Noel John Aherne

  4. Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy

    Article • Asia-Pacific Journal of Clinical Oncology, May 2014, Wiley

    Dr Noel John Aherne